EndoTool® Platform Enhancement & Regulatory Adaptation

About Monarch Medical Technologies

Monarch Medical Technologies is a long-established, commercial-stage digital health company with a singular, validated product: the EndoTool® insulin dosing system. The platform uses a proprietary algorithm to personalize insulin therapy for hospitalized patients, aiming to improve glycemic control while minimizing hypoglycemia risk. It has a proven track record with numerous US hospital customers, is supported by clinical evidence, and is positioned to benefit from increasing regulatory focus on inpatient glycemic safety metrics. The company operates as a private entity, generating revenue through its software-as-a-service (SaaS) model for healthcare providers.

Therapeutic Areas